• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于描述从新生儿到成人肾功能的无脂肪质量、肌酐清除率和肾小球滤过率的一致方法。

Consistent methods for fat-free mass, creatinine clearance, and glomerular filtration rate to describe renal function from neonates to adults.

机构信息

Department of Pharmacology & Clinical Pharmacology, University of Auckland, Auckland, New Zealand.

Department of Anesthesia, Auckland Hospital, Auckland, New Zealand.

出版信息

CPT Pharmacometrics Syst Pharmacol. 2023 Mar;12(3):401-412. doi: 10.1002/psp4.12924. Epub 2023 Feb 7.

DOI:10.1002/psp4.12924
PMID:36691877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10014044/
Abstract

Quantifying the effect of kidney disease on glomerular filtration rate (GFR) is important when describing variability in the clearance of drugs eliminated by the kidney. We aimed to develop a continuous model for renal function (RF) from prematurity to adulthood based on consistent models for fat-free mass (FFM), creatinine production rate (CPR), and GFR. A model for fractional FFM in premature neonates to adults was developed using pooled data from 4462 subjects and 2847 FFM observations. It was found that girls have an FFM higher than that predicted from adult women based on height, total body mass, and sex, and boys have an FFM lower than adult men until around the onset of puberty, when it approaches adult male values. Data from 108 subjects with measurements of serum creatinine (Scr) and GFR were used to construct a model for CPR. Creatinine clearance was predicted using a model for CPR (based on FFM, postmenstrual age, and sex) and Scr that avoids discontinuous predictions between neonates, children, and adults. Individual CPR may then be used with individual Scr to predict the estimated GFR (eGFR; eGFR = CPR/Scr). A previously published model for human GFR based on 1153 GFR observations in 923 subjects without known kidney disease was updated using the model for fractional FFM to predict individual size and age-consistent values for the expected normal GFR (nGFR). Individual renal function was then calculated using RF = eGFR/nGFR.

摘要

定量评估肾脏疾病对肾小球滤过率(GFR)的影响对于描述肾脏清除药物的变异性非常重要。我们旨在基于无脂肪质量(FFM)、肌酐生成率(CPR)和 GFR 的一致模型,从早产儿到成年期开发连续的肾功能(RF)模型。使用来自 4462 名受试者和 2847 个 FFM 观察值的汇总数据,开发了一种用于早产儿到成年期的分数 FFM 的模型。结果发现,女孩的 FFM 高于根据身高、总体质量和性别预测的成年女性的 FFM,男孩的 FFM 低于成年男性,直到青春期开始,此时接近成年男性的数值。使用来自 108 名受试者的血清肌酐(Scr)和 GFR 测量值的数据构建了 CPR 模型。使用基于 FFM、绝经后年龄和性别的 CPR 模型(基于 FFM、绝经后年龄和性别)和 Scr 预测肌酐清除率,避免了在新生儿、儿童和成人之间的不连续预测。然后可以使用个体 CPR 和个体 Scr 预测估计的肾小球滤过率(eGFR;eGFR=CPR/Scr)。使用来自 923 名无已知肾脏疾病的受试者的 1153 个 GFR 观察值的先前发表的人类 GFR 模型,通过分数 FFM 模型进行更新,以预测个体大小和年龄一致的预期正常 GFR(nGFR)的数值。然后使用 RF=eGFR/nGFR 计算个体肾功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25ce/10014044/1e9d2fd29998/PSP4-12-401-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25ce/10014044/2e2b1790de44/PSP4-12-401-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25ce/10014044/863fe99aadc3/PSP4-12-401-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25ce/10014044/660f3dc62565/PSP4-12-401-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25ce/10014044/1e9d2fd29998/PSP4-12-401-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25ce/10014044/2e2b1790de44/PSP4-12-401-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25ce/10014044/863fe99aadc3/PSP4-12-401-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25ce/10014044/660f3dc62565/PSP4-12-401-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25ce/10014044/1e9d2fd29998/PSP4-12-401-g004.jpg

相似文献

1
Consistent methods for fat-free mass, creatinine clearance, and glomerular filtration rate to describe renal function from neonates to adults.用于描述从新生儿到成人肾功能的无脂肪质量、肌酐清除率和肾小球滤过率的一致方法。
CPT Pharmacometrics Syst Pharmacol. 2023 Mar;12(3):401-412. doi: 10.1002/psp4.12924. Epub 2023 Feb 7.
2
Glomerular filtration rate in critically ill neonates and children: creatinine-based estimations versus iohexol-based measurements.危重新生儿和儿童的肾小球滤过率:基于肌酐的估算与基于碘海醇的测量。
Pediatr Nephrol. 2023 Apr;38(4):1087-1097. doi: 10.1007/s00467-022-05651-w. Epub 2022 Aug 2.
3
Reliability of glomerular filtration rate estimating formulas compared to iohexol plasma clearance in critically ill children.比较不同肾小球滤过率估算公式与碘海醇血浆清除率在危重症患儿中的可靠性。
Eur J Pediatr. 2022 Nov;181(11):3851-3866. doi: 10.1007/s00431-022-04570-0. Epub 2022 Sep 2.
4
Assessment of Split Renal Function Using a Combination of Contrast-Enhanced CT and Serum Creatinine Values for Glomerular Filtration Rate Estimation.采用对比增强 CT 和血清肌酐值联合评估分肾功能以估算肾小球滤过率。
AJR Am J Roentgenol. 2020 Jul;215(1):142-147. doi: 10.2214/AJR.19.22125. Epub 2020 Apr 7.
5
Proenkephalin A as a marker for glomerular filtration rate in critically ill children: validation against gold standard iohexol GFR measurements.脑啡肽原 A 作为危重症儿童肾小球滤过率的标志物:与金标准碘海醇 GFR 测量值的验证。
Clin Chem Lab Med. 2022 Oct 27;61(1):104-111. doi: 10.1515/cclm-2022-0545. Print 2023 Jan 27.
6
Cystatin C, beta 2-microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: comparison with plasma creatinine.胱抑素C、β2-微球蛋白和视黄醇结合蛋白作为肾小球滤过率的指标:与血肌酐的比较。
J Pharm Biomed Anal. 2001 Mar;24(5-6):835-42. doi: 10.1016/s0731-7085(00)00550-1.
7
Comparison of creatinine based and kidney volume based methods of estimating glomerular filtration rates in potential living kidney donors.比较基于肌酐和基于肾体积的肾小球滤过率估计方法在潜在活体供肾者中的应用。
J Urol. 2013 Nov;190(5):1820-6. doi: 10.1016/j.juro.2013.05.117. Epub 2013 Jun 11.
8
Role of lean body mass for estimation of glomerular filtration rate in patients with chronic kidney disease with various body mass indices.瘦体重在估算不同体重指数的慢性肾脏病患者肾小球滤过率中的作用。
Scand J Urol Nephrol. 2009;43(2):171-6. doi: 10.1080/00365590802502228.
9
Prospective pediatric study comparing glomerular filtration rate estimates based on motion-robust dynamic contrast-enhanced magnetic resonance imaging and serum creatinine (eGFR) to Tc DTPA.前瞻性儿科研究比较基于运动稳健的动态对比增强磁共振成像和血清肌酐(eGFR)与 Tc DTPA 的肾小球滤过率估计值。
Pediatr Radiol. 2020 May;50(5):698-705. doi: 10.1007/s00247-020-04617-0. Epub 2020 Jan 27.
10
Serum creatinine can be used as a surrogate for glomerular filtration rate in single renal unit models.在单肾单位模型中,血清肌酐可作为肾小球滤过率的替代指标。
Can J Urol. 2009 Feb;16(1):4452-7; discussion 4457.

引用本文的文献

1
Personalized tobramycin dosing in children with cystic fibrosis: an AUC-guided approach.囊性纤维化患儿的妥布霉素个体化给药:一种基于药时曲线下面积(AUC)指导的方法。
Antimicrob Agents Chemother. 2025 Sep 3;69(9):e0027825. doi: 10.1128/aac.00278-25. Epub 2025 Jul 23.
2
Exploring the Influence of Obesity and CYP2 C19 Genotype on Lansoprazole Pharmacokinetics in Pediatric Patients: A Population Modeling Approach.探索肥胖和CYP2C19基因型对儿科患者兰索拉唑药代动力学的影响:一种群体建模方法。
Clin Pharmacokinet. 2025 May 16. doi: 10.1007/s40262-025-01517-0.
3
Physiologically Based and Population Pharmacokinetic Modeling of Midazolam in Children With Obesity Using Real-World Data.

本文引用的文献

1
Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race.基于种族无关方程估算肾小球滤过率与黑种人与非黑种人肾衰竭和死亡率的关联。
JAMA. 2022 Jun 21;327(23):2306-2316. doi: 10.1001/jama.2022.8801.
2
Performance of creatinine-based equations to estimate glomerular filtration rate with a methodology adapted to the context of drug dosage adjustment.基于肌酐的方程在药物剂量调整背景下适应方法学的肾小球滤过率估计的表现。
Br J Clin Pharmacol. 2022 May;88(5):2118-2127. doi: 10.1111/bcp.15132. Epub 2021 Dec 3.
3
Race, Genetic Ancestry, and Estimating Kidney Function in CKD.
利用真实世界数据对肥胖儿童咪达唑仑进行基于生理的群体药代动力学建模
Clin Transl Sci. 2025 May;18(5):e70247. doi: 10.1111/cts.70247.
4
A Review of Vancomycin, Gentamicin, and Amikacin Population Pharmacokinetic Models in Neonates and Infants.新生儿和婴儿中万古霉素、庆大霉素和阿米卡星群体药代动力学模型综述
Clin Pharmacokinet. 2025 Jan;64(1):1-25. doi: 10.1007/s40262-024-01459-z. Epub 2025 Jan 16.
5
Spotlight commentary: Changes in pharmacokinetics following significant weight loss.焦点评论:显著体重减轻后的药代动力学变化
Br J Clin Pharmacol. 2025 Mar;91(3):678-680. doi: 10.1111/bcp.16401. Epub 2025 Jan 15.
6
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population.表征依诺肝素的群体药代动力学以指导儿科人群的个体化剂量。
Clin Pharmacokinet. 2024 Jul;63(7):999-1014. doi: 10.1007/s40262-024-01388-x. Epub 2024 Jul 2.
7
Personalized Dosing of Medicines for Children: A Primer on Pediatric Pharmacometrics for Clinicians.儿童个体化药物剂量:临床医师小儿药代动力学实用指南。
Paediatr Drugs. 2024 Jul;26(4):365-379. doi: 10.1007/s40272-024-00633-x. Epub 2024 May 16.
8
Time-Varying Clearance in Milrinone Pharmacokinetics from Premature Neonates to Adolescents.米力农药代动力学中从早产儿到青少年的时变清除率。
Clin Pharmacokinet. 2024 May;63(5):695-706. doi: 10.1007/s40262-024-01372-5. Epub 2024 Apr 13.
9
When will the Glomerular Filtration Rate in Former Preterm Neonates Catch up with Their Term Peers?曾经的早产儿肾小球滤过率何时能赶上足月同龄人?
Pharm Res. 2024 Apr;41(4):637-649. doi: 10.1007/s11095-024-03677-3. Epub 2024 Mar 12.
10
Pediatric oncology drug development and dosage optimization.儿科肿瘤学药物研发与剂量优化
Front Oncol. 2024 Jan 29;13:1235947. doi: 10.3389/fonc.2023.1235947. eCollection 2023.
种族、遗传背景与慢性肾脏病中肾功能的评估。
N Engl J Med. 2021 Nov 4;385(19):1750-1760. doi: 10.1056/NEJMoa2103753. Epub 2021 Sep 23.
4
In Search of a Better Equation - Performance and Equity in Estimates of Kidney Function.寻找更好的公式——肾功能评估中的性能与公平性
N Engl J Med. 2021 Feb 4;384(5):396-399. doi: 10.1056/NEJMp2028243. Epub 2021 Jan 6.
5
Hidden in Plain Sight - Reconsidering the Use of Race Correction in Clinical Algorithms.隐匿于众目睽睽之下——重新审视临床算法中种族校正的应用
N Engl J Med. 2020 Aug 27;383(9):874-882. doi: 10.1056/NEJMms2004740. Epub 2020 Jun 17.
6
Authors' Reply to Friesen: "An Extension of Janmahasatian's Fat-Free Mass Model for Universal Application Across Populations of Different Ethnicities".作者对弗里森的回复:“扬马哈萨蒂安无脂肪体重模型在不同种族人群中的通用扩展”
Clin Pharmacokinet. 2020 Oct;59(10):1315. doi: 10.1007/s40262-020-00906-x.
7
Kidney Disease, Race, and GFR Estimation.肾脏病、种族与肾小球滤过率估计。
Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1203-1212. doi: 10.2215/CJN.12791019. Epub 2020 May 11.
8
Estimating glomerular filtration rate at the transition from pediatric to adult care.估算儿科向成人护理过渡时的肾小球滤过率。
Kidney Int. 2019 May;95(5):1234-1243. doi: 10.1016/j.kint.2018.12.020. Epub 2019 Feb 28.
9
Negligible impact of birth on renal function and drug metabolism.出生对肾功能和药物代谢的影响可忽略不计。
Paediatr Anaesth. 2018 Nov;28(11):1015-1021. doi: 10.1111/pan.13497. Epub 2018 Oct 10.
10
Allometric size: The scientific theory and extension to normal fat mass.异速生长大小:科学理论及其对正常脂肪量的扩展。
Eur J Pharm Sci. 2017 Nov 15;109S:S59-S64. doi: 10.1016/j.ejps.2017.05.056. Epub 2017 May 25.